Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-03-31 @ 1:22 PM
Study NCT ID:
NCT03280160
Status:
UNKNOWN
Last Update Posted:
2022-09-16
First Post:
2017-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab
Sponsor:
Organization: